NanoLinea Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

NanoLinea General Information


Provider of therapeutic implant treatment for cardiac ventricular arrhythmia. The company creates medical devices based on carbon nanotube fiber technology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Hospitals/Inpatient Services
Primary Office
  • 2431 Shakespeare Street
  • Suite 1
  • Houston, TX 77030
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoLinea Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 09-Mar-2015 Completed Startup
To view NanoLinea’s complete valuation and funding history, request access »

NanoLinea Executive Team (2)

Name Title Board Seat Contact Info
Colin Young Co-Founder & Chief Executive Officer
Mehdi Razavi MD Co-Founder
To view NanoLinea’s complete executive team members history, request access »

NanoLinea Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TMC Innovation Accelerator/Incubator 000 0000 000000 0
To view NanoLinea’s complete investors history, request access »